GAD1 and prostate adenocarcinoma: Basic information about patients in the TCGA-PRAD cohort is detailed in Additional file 7: Table S3. GAD1 expression was found to be higher in the T3 and N1 stages than in the T2 and N0 stages, respectively (Fig. 3B, C).